Barclays PLC Merck & Co., Inc. Put Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Put Options

26 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 15, 2024	BUY	$111.15 - $128.97 $16.6 Million - $19.3 Million	149,600 New	149,600 $17 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $7.37 Million - $8.59 Million	-65,100 Reduced 47.87%	70,900 $9.36 Million
Q4 2023 Feb 15, 2024	BUY	$100.18 - $109.02 $13.6 Million - $14.8 Million	136,000 New	136,000 $14.8 Million
Q1 2023 May 04, 2023	SELL	$102.94 - $114.86 $26 Million - $29 Million	-252,200 Reduced 42.54%	340,600 $36.2 Million
Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $26.9 Million - $34.5 Million	307,400 Added 107.71%	592,800 $65.8 Million
Q3 2022 Nov 03, 2022	BUY	$84.53 - $94.96 $15.9 Million - $17.9 Million	188,000 Added 193.02%	285,400 $24.6 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $5.18 Million - $5.87 Million	62,000 Added 175.14%	97,400 $8.88 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $654,239 - $733,360	-8,900 Reduced 20.09%	35,400 $2.9 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $7.29 Million - $9.14 Million	-100,900 Reduced 69.49%	44,300 $3.4 Million
Q3 2021 Nov 09, 2021	BUY	$71.68 - $78.83 $2.87 Million - $3.16 Million	40,100 Added 38.15%	145,200 $10.9 Million
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $5.62 Million - $6.22 Million	80,000 Added 318.73%	105,100 $8.17 Million
Q1 2021 May 13, 2021	SELL	$68.86 - $81.11 $24.6 Million - $29 Million	-357,300 Reduced 93.44%	25,100 $1.94 Million
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $19 Million - $21 Million	264,200 Added 223.52%	382,400 $31.3 Million
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $2.03 Million - $2.3 Million	27,700 Added 30.61%	118,200 $9.8 Million
Q2 2020 Aug 12, 2020	SELL	$70.42 - $80.13 $15.2 Million - $17.3 Million	-216,500 Reduced 70.52%	90,500 $7 Million
Q1 2020 May 13, 2020	SELL	$63.36 - $87.82 $23.8 Million - $33 Million	-375,400 Reduced 55.01%	307,000 $23.6 Million
Q4 2019 Feb 10, 2020	BUY	$77.58 - $87.54 $13.4 Million - $15.1 Million	172,200 Added 33.75%	682,400 $62.1 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $12.6 Million - $13.7 Million	-165,300 Reduced 24.47%	510,200 $42.9 Million
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $32.2 Million - $37.6 Million	460,600 Added 214.33%	675,500 $56.6 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $24.5 Million - $27.9 Million	-351,700 Reduced 62.07%	214,900 $17.9 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $13.2 Million - $15.4 Million	202,800 Added 55.74%	566,600 $43.3 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $36.3 Million - $42.7 Million	-629,600 Reduced 63.38%	363,800 $25.8 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $28.9 Million - $33.9 Million	-568,400 Reduced 36.39%	993,400 $60.3 Million
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $1.62 Million - $1.88 Million	-31,700 Reduced 1.99%	1,561,800 $85.1 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $62.3 Million - $74.4 Million	1,207,600 Added 312.93%	1,593,500 $89.7 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $22.6 Million - $24.4 Million	385,900	385,900 $24.7 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$24.5 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$20.3 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$11.7 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.43 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$5.8 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account